171 related articles for article (PubMed ID: 20072809)
1. Statin drugs, serum cholesterol, and prostate-specific antigen in the National Health and Nutrition Examination Survey 2001-2004.
Mondul AM; Selvin E; De Marzo AM; Freedland SJ; Platz EA
Cancer Causes Control; 2010 May; 21(5):671-8. PubMed ID: 20072809
[TBL] [Abstract][Full Text] [Related]
2. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
3. Associations among statins, preventive care, and prostate cancer mortality.
Kumar A; Riviere P; Luterstein E; Nalawade V; Vitzthum L; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):475-485. PubMed ID: 32029930
[TBL] [Abstract][Full Text] [Related]
4. Minimal detection bias in the inverse association between statin drug use and advanced prostate cancer risk: a simulation study.
Mondul AM; Caffo B; Platz EA
Cancer Epidemiol; 2011 Aug; 35(4):e6-11. PubMed ID: 21167804
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial.
Murtola TJ; Tammela TL; Määttänen L; Huhtala H; Platz EA; Ala-Opas M; Stenman UH; Auvinen A
Int J Cancer; 2010 Oct; 127(7):1650-9. PubMed ID: 20073066
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Screening for Prostate Cancer Among Men Who Use Statins.
Vettenranta A; Murtola TJ; Raitanen J; Raittinen P; Talala K; Taari K; Stenman UH; Tammela TLJ; Auvinen A
JAMA Oncol; 2022 Jan; 8(1):61-68. PubMed ID: 34817559
[TBL] [Abstract][Full Text] [Related]
7. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
[TBL] [Abstract][Full Text] [Related]
8. The associations between statin use and prostate cancer screening, prostate size, high-grade prostatic intraepithelial neoplasia (PIN), and prostate cancer.
Fowke JH; Motley SS; Barocas DA; Cookson MS; Concepcion R; Byerly S; Smith JA
Cancer Causes Control; 2011 Mar; 22(3):417-26. PubMed ID: 21170754
[TBL] [Abstract][Full Text] [Related]
9. Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity.
Algotar AM; Thompson PA; Ranger-Moore J; Stratton MS; Hsu CH; Ahmann FR; Nagle RB; Stratton SP
Prostate; 2010 Jun; 70(8):883-8. PubMed ID: 20135645
[TBL] [Abstract][Full Text] [Related]
10. Statin medications are associated with a lower probability of having an abnormal screening prostate-specific antigen result.
Shi Y; Fung KZ; Freedland SJ; Hoffman RM; Tang VL; Walter LC
Urology; 2014 Nov; 84(5):1058-65. PubMed ID: 25443902
[TBL] [Abstract][Full Text] [Related]
11. The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: a preliminary report.
Cyrus-David MS; Weinberg A; Thompson T; Kadmon D
J Urol; 2005 Jun; 173(6):1923-5. PubMed ID: 15879782
[TBL] [Abstract][Full Text] [Related]
12. Is PSA related to serum cholesterol and does the relationship differ between black and white men?
Zapata D; Howard LE; Allott EH; Hamilton RJ; Goldberg K; Freedland SJ
Prostate; 2015 Dec; 75(16):1877-85. PubMed ID: 26332663
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Statin Use Associated With Lower PSA But Similar Prostate Size and Histopathologic Outcomes: Implications for Active Surveillance?
Stensland K; McBride RB; Leapman M; Hobbs A; Jazayeri SB; Samadi DB
Urol J; 2017 May; 14(3):3064-3070. PubMed ID: 28537044
[TBL] [Abstract][Full Text] [Related]
14. The association between clinically determined periodontal disease and prostate-specific antigen concentration in men without prostate cancer: the 2009-2010 National Health and Nutrition Examination Survey.
Huang Y; Michaud DS; Lu J; Carter HB; Platz EA
Cancer Causes Control; 2019 Dec; 30(12):1293-1300. PubMed ID: 31637561
[TBL] [Abstract][Full Text] [Related]
15. Association of Treatment With 5α-Reductase Inhibitors With Time to Diagnosis and Mortality in Prostate Cancer.
Sarkar RR; Parsons JK; Bryant AK; Ryan ST; Kader AK; McKay RR; D'Amico AV; Nguyen PL; Hulley BJ; Einck JP; Mundt AJ; Kane CJ; Murphy JD; Rose BS
JAMA Intern Med; 2019 Jun; 179(6):812-819. PubMed ID: 31058923
[TBL] [Abstract][Full Text] [Related]
16. The association between statin use and the diagnosis of prostate cancer in a population based cohort.
Breau RH; Karnes RJ; Jacobson DJ; McGree ME; Jacobsen SJ; Nehra A; Lieber MM; St Sauver JL
J Urol; 2010 Aug; 184(2):494-9. PubMed ID: 20620405
[TBL] [Abstract][Full Text] [Related]
17. Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial.
Allott EH; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
Cancer Prev Res (Phila); 2017 Jun; 10(6):319-326. PubMed ID: 28487295
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer survival among statin users after prostatectomy in a Finnish nationwide cohort.
Joentausta RM; Rannikko A; Murtola TJ
Prostate; 2019 May; 79(6):583-591. PubMed ID: 30652328
[TBL] [Abstract][Full Text] [Related]
19. Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.
Morote J; Celma A; Planas J; Placer J; de Torres I; Olivan M; Carles J; Reventós J; Doll A
Int J Mol Sci; 2014 Aug; 15(8):13615-23. PubMed ID: 25101846
[TBL] [Abstract][Full Text] [Related]
20. Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males.
Khosropanah I; Falahatkar S; Farhat B; Heidari Bateni Z; Enshaei A; Allahkhah AA; Khosropanah D
Acta Med Iran; 2011; 49(12):789-94. PubMed ID: 22174166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
